{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:00:21Z","timestamp":1789984821357,"version":"4.0.1"},"reference-count":19,"publisher":"Wiley","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EFS2","EFSA Journal"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on cannabidiol (CBD) obtained by chemical synthesis as a novel food (NF) pursuant to Regulation (EU) 2015\/2283. The NF consists of \u2265\u200998% (w\/w) CBD and is intended to be marketed exclusively dissolved in medium\u2010chain triglyceride (MCT) oil in food supplements at a maximum daily dose of 2 mg. The proposed target population is the general adult population over 25\u2009years old and excluding pregnant and lactating women. The safety of CBD in individuals taking medications cannot be established. The information provided on the production process, composition and specifications of the NF does not raise safety concerns. The NF is not considered to be nutritionally disadvantageous, and no concerns were identified with respect to genotoxicity. The applicant submitted a 90\u2010day subchronic oral toxicity study with the NF in which the liver was identified as the key target organ, with female rats being more sensitive than males. A BMDL10 of 10.5 mg\/kg bw of CBD per day was derived for increased liver weight relative to body weight in female rats. In view of the remaining data gaps, including those related to reproductive and developmental toxicity, the uncertainty factor proposed in the Updated Statement on the safety of CBD published by EFSA in 2026 (i.e. 400) was applied to derive a safe intake level for cannabidiol of 0.026 mg\/kg bw per day (2 mg\/day for a 70\u2010kg adult). The Panel concludes that the NF is safe under the proposed conditions of use, except for people taking medication, for whom safety could not be established.<\/jats:p>","DOI":"10.2903\/j.efsa.2026.10154","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:15:25Z","timestamp":1789722925000},"source":"Crossref","is-referenced-by-count":0,"title":["Safety of synthetic cannabidiol as a novel food pursuant to regulation (EU) 2015\/2283"],"prefix":"10.2903","volume":"24","author":[{"name":"EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Turck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Bohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monta\u00f1a","family":"C\u00e1mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Castenmiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan","family":"De Henauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngeles","family":"Jos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Maciuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Mangelsdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breige","family":"McNulty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Androniki","family":"Naska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Pentieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Siani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Thies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cubadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.","family":"McArdle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Trezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oc\u00e9ane","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Beneventi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Laganaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Nuin Garciarena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n Berr\u00edo","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Seminati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Magani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Ildico","family":"Hirsch\u2010Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.2903\/j.efsa.2026.10154_ref1","doi-asserted-by":"crossref","unstructured":"Ahmad Alhadid, A., Luca, S. V., Nasrallah, S., & Minceva, M. (2023). Experimental investigation and thermodynamic modeling of cannabidiol solubility in plant oils and hydrophobic eutectic systems. Journal of Molecular Liquids, 372, 121172. https:\/\/doi.org\/10.1016\/j.molliq.2023.121172","DOI":"10.1016\/j.molliq.2022.121172"},{"key":"#cr-split#-10.2903\/j.efsa.2026.10154_ref2.1","unstructured":"EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies) . (2016). Guidance on the preparation and presentation of an application for authorisation of a novel food in the context of regulation"},{"key":"#cr-split#-10.2903\/j.efsa.2026.10154_ref2.2","doi-asserted-by":"crossref","unstructured":"(EU) 2015\/2283. EFSA Journal, 14(11), 4594. https:\/\/doi.org\/10.2903\/j.efsa.2016.4594","DOI":"10.2903\/j.efsa.2016.4594"},{"key":"10.2903\/j.efsa.2026.10154_ref3","doi-asserted-by":"crossref","unstructured":"EFSA NDA Panel (EFSA Panel on Nutrition, Novel Foods and Food Allergens) . (2022). Statement on safety of cannabidiol as a novel food: Data gaps and uncertainties. EFSA Journal, 20(6), 7322. https:\/\/doi.org\/10.2903\/j.efsa.2022.7322","DOI":"10.2903\/j.efsa.2022.7322"},{"key":"10.2903\/j.efsa.2026.10154_ref4","doi-asserted-by":"crossref","unstructured":"EFSA NDA Panel (EFSA Panel on Nutrition, Novel Foods and Food Allergens) . (2026). Update of the statement on safety of cannabidiol as a novel food. EFSA Journal, 24(2), e9862. https:\/\/doi.org\/10.2903\/j.efsa.2026.9862","DOI":"10.2903\/j.efsa.2026.9862"},{"key":"10.2903\/j.efsa.2026.10154_ref5","doi-asserted-by":"crossref","unstructured":"EFSA Scientific Committee . (2017). Scientific Opinion on the clarification of some aspects related to genotoxicity assessment. EFSA Journal, 15(12), 5113. https:\/\/doi.org\/10.2903\/j.efsa.2017.5113","DOI":"10.2903\/j.efsa.2017.5113"},{"key":"10.2903\/j.efsa.2026.10154_ref6","unstructured":"EFSA Scientific Committee . (2021). Guidance on technical requirements for regulated food and feed product applications to establish the presence of small particles including nanoparticles. EFSA Journal, 19(8), 6769. https:\/\/doi.org\/10.2903\/j.efsa.2021.676 Annex B available at: https:\/\/efsa.onlinelibrary.wiley.com\/action\/downloadSupplement?doi=10.2903%2Fj.efsa.2021.6769&file=efs26769\u2010sup\u20100002\u2010Annex_B.pdf."},{"key":"10.2903\/j.efsa.2026.10154_ref7","doi-asserted-by":"crossref","unstructured":"EFSA Scientific Committee . (2022). Guidance on the use of the benchmark dose approach in risk assessment. EFSA Journal, 20(10), 7584. https:\/\/doi.org\/10.2903\/j.efsa.2022.7584","DOI":"10.2903\/j.efsa.2022.7584"},{"key":"10.2903\/j.efsa.2026.10154_ref8","unstructured":"OECD (Organisation for Economic Co\u2010Operation and Development) . (1997). Test no. 471: Bacterial reverse mutation test. OECD guidelines for the testing of chemicals, section\u00a04, OECD Publishing, Paris, 11 (Corrected 2020). https:\/\/doi.org\/10.1787\/9789264071247\u2010en"},{"key":"10.2903\/j.efsa.2026.10154_ref9","unstructured":"OECD (Organisation for Economic Co\u2010Operation and Development) . (1998). OECD principles on good laboratory practice, OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring, No. 1, OECD Publishing, Paris. https:\/\/doi.org\/10.1787\/9789264078536\u2010en"},{"key":"10.2903\/j.efsa.2026.10154_ref10","unstructured":"OECD (Organisation for Economic Co\u2010Operation and Development) . (2016a). Test no. 487: In\u00a0vitro mammalian cell micronucleus test. OECD guidelines for the testing of chemicals, section\u00a04, OECD Publishing, Paris, 23 (Corrected 2023). https:\/\/doi.org\/10.1787\/9789264264861\u2010en"},{"key":"10.2903\/j.efsa.2026.10154_ref11","unstructured":"OECD (Organisation for Economic Co\u2010Operation and Development) . (2016b). Test No. 474: Mammalian erythrocyte micronucleus test, OECD Guidelines for the Testing of Chemicals, Section\u00a04, OECD Publishing, Paris. https:\/\/doi.org\/10.1787\/9789264264762\u2010en"},{"key":"10.2903\/j.efsa.2026.10154_ref12","unstructured":"OECD (Organisation for Economic Co\u2010operation and Development) . (2018). Test No. 408: Repeated dose 90\u2010day Oral toxicity study in rodents. Paris: OECD Publishing. (Corrected 2025). https:\/\/doi.org\/10.1787\/9789264070707\u2010en"},{"key":"10.2903\/j.efsa.2026.10154_ref13","unstructured":"Unpublished . (2019). A 14 Day Dose Range\u2010Finding Study of Cannabidiol by Oral (Gavage) in the Rat (No GLP)."},{"key":"10.2903\/j.efsa.2026.10154_ref14","unstructured":"Unpublished . (2020a). Cannabidiol: Bacterial Reverse Mutation Test (GLP, OECD TG 471)."},{"key":"10.2903\/j.efsa.2026.10154_ref15","unstructured":"Unpublished . (2020b). Cannabidiol: In\u00a0Vitro Mammalian Cell Micronucleus Test (GLP, OECD TG 478)."},{"key":"10.2903\/j.efsa.2026.10154_ref16","unstructured":"Unpublished . (2020c). Cannabidiol: Mammalian Erythrocyte Micronucleus Test in the Rat (GLP, OECD TG 474)."},{"key":"10.2903\/j.efsa.2026.10154_ref17","unstructured":"Unpublished . (2020d). Cannabidiol: A 90\u2010Day Toxicity Study by Oral (Gavage) in the Rat (GLP, OECD TG 408)."},{"key":"10.2903\/j.efsa.2026.10154_ref18","unstructured":"Unpublished . (2022). In vitro Mammalian Cell Micronucleus Test On Cultured Human Lymphocytes Coupled to the Fluorescence in\u00a0situ hybridization (FISH) (GLP, OECD TG 478)."}],"container-title":["EFSA Journal"],"original-title":[],"link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.2903\/j.efsa.2026.10154","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.2903\/j.efsa.2026.10154\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:00:35Z","timestamp":1789981235000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.2903\/j.efsa.2026.10154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":19,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.2903\/j.efsa.2026.10154","relation":{},"ISSN":["1831-4732","1831-4732"],"issn-type":[{"value":"1831-4732","type":"print"},{"value":"1831-4732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}